Cytisinicline

Name: Cytisinicline in Smoking cessation: Humanistic burden and health-related quality of life
Published: 2026-09-14T15:39:06-04:00

Smoking cessation

Manufacturer: Achieve Life Sciences
Regulatory submission: NDA resubmission planned for the fourth quarter of 2026
Launch: Anticipated after potential approval in the first half of 2027
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description Burden of Smoking cessation

Humanistic burden and health-related quality of life

1 evidence topic · 2 sources

Quality of life after smoking cessation

“Compared to continuing smokers, quitters showed improved global QOL, HR-QOL, and affect at Years 1 and 3” (opens the source at this quote in a new tab)